Category: Business and Investments
Methylgene to receive equity investment from Otsuka Pharmaceutical
MethylGene Inc. (TSX: MYG) agreed to issue 3,686,182 common shares to Otsuka Pharmaceutical Co., Ltd. …
Provectus starts compassionate use program for PV-10
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) expanded its compassionate use program for PV-10, making the agent, …
Positive Palifosfamide Sarcoma Phase II Data from ZIOPHARM
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced positive data from the multicenter randomized Phase II trial …
Positive clinical trial results for Epeius
Epeius Biotechnologies Corporation announced results of its Rexin-G® clinical trials. Administered as stand-alone therapy in …
Locus Pharmaceuticals and Novartis enter into research collaboration
Locus Pharmaceuticals has entered into a discovery research collaboration with Novartis. Locus will collaborate with …
UsiRNA reduces tumor growth in vivo
MDRNA, Inc. (NASDAQ: MRNA) presented new in vivo data showing continued progress in the advancement …
Medicago awarded U.S. Army contract
Medicago Inc. (TSX-V: MDG) has been awarded a proof of concept contract by the U.S. …
Novavax gets NIH grant
Novavax, Inc. (NASDAQ:NVAX) has received a Small Business and Innovation Research grant from the National …
Canadian patent strengthens IP for Allon’s 2nd technology platform
Allon Therapeutics Inc. (TSX: NPC), announced today that the intellectual property underlying its activity-dependent neurotrophic …
Hana Biosciences completes private placement
Hana Biosciences (OTCBB:HNAB) has completed its previously disclosed private placement of units of its securities …